Search Within

Sergio Andres Giralt

  1. "Master of Science in Clinical and Translational Cancer Research "
Formats
  1. Meeting Abstract (244)
  2. Journal Article (120)
  3. Research Letter (10)
  4. Review (7)
Groups
  1. Bone Marrow Transplant (381)
  2. CTCR Scholars (381)
  3. Center for Hematologic Malignancies (381)
  4. Department of Medicine (381)
  5. Hematologic Malignancies, Division of (381)
  6. MSK Grad Students (381)

More Groups

People
  1. Miguel-Angel Perales (288)
  2. Sean Devlin (220)
  3. Parastoo Dahi (207)
  4. Doris Ponce (193)
  5. Ann Jakubowski (169)
  6. Esperanza Papadopoulos (165)

More People

Years
  1. 2025 (5)
  2. 2024 (9)
  3. 2023 (32)
  4. 2022 (32)
  5. 2021 (31)
  6. 2020 (45)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (131)
  2. Blood (111)
  3. Bone Marrow Transplantation (38)
  4. Transplantation and Cellular Therapy (23)
  5. Blood Advances (18)
  6. Leukemia and Lymphoma (8)

More Publications

Publishers
  1. Elsevier Inc. (159)
  2. American Society of Hematology (129)
  3. Nature Publishing Group (41)
  4. Taylor & Francis Group (10)
  5. American Society of Clinical Oncology (5)
  6. Oxford University Press (5)

More Publishers

Results (381)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Five-year experience using bridging radiotherapy prior to chimeric antigen receptor (CAR) T-cell therapies for B-cell malignancies at Memorial Sloan Kettering Cancer Center
    Meeting Abstract

    Silverman, E. A.; Hubbeling, H.; Palomba, M. L.; Wijetunga, N. A.; Tringale, K.; Lebow, E.; Tomas, A. A.; Shouval, R.; Batlevi, C. L.; Brentjens, R. J.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Daratumumab versus lenalidomide maintenance therapy for multiple myeloma: A randomized pilot study comparing patient-reported health related quality of life measures
    Meeting Abstract

    Shah, U. A.; Malik, M.; Werner, K.; Burge, M.; Devlin, S. M.; Mailankody, S.; Korde, N.; Hultcrantz, M.; Hassoun, H.; Tan, C.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Lesion characteristics and patterns of failure in diffuse large B cell lymphoma patients treated with bridging radiotherapy prior to chimeric antigen receptor T cell therapy
    Meeting Abstract

    Hubbeling, H.; Silverman, E. A.; Wijetunga, N. A.; Palomba, M. L.; Tringale, K.; Lebow, E.; Tomas, A. A.; Shouval, R.; Batlevi, C. L.; Brentjens, R. J.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Racial disparities in access to alternative donor allografts persist in the era of "Donors for all"
    Meeting Abstract

    Fingrut, W.; Politikos, I.; Davis, E.; Chinapen, S.; Naputo, K.; Cho, C.; Giralt, S. A.; Gyurkocza, B.; Jakubowski, A. A.; Papadopoulos, E. B.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • MAIT and Vδ2 unconventional T cells predict favorable outcome after allogeneic HCT and are supported by a diverse intestinal microbiome
    Meeting Abstract

    Andrlova, H.; Miltiadous, O.; Dai, A.; Gardner, R.; El Daker, S.; Slingerland, J. B.; Giardina, P. A.; Clurman, A.; Gomes, A. L. C.; Nguyen, C. L.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Venetoclax-based combinations in AML and high-risk MDS prior to and following allogeneic hematopoietic cell transplant
    Journal Article

    Bewersdorf, J. P.; Derkach, A.; Gowda, L.; Menghrajani, K.; DeWolf, S.; Ruiz, J. D.; Ponce, D. M.; Shaffer, B. C.; Tamari, R.; Young, J. W.; more...
    Leukemia and Lymphoma (2021)

    Fulltext@MSK | Save
  • Successful incorporation of electronic patient-reported outcomes using PROMIS-29 into standard of care for lymphoma patients receiving CD19-directed chimeric antigen receptor T (CAR T) cell therapy
    Meeting Abstract

    Shah, G. L.; Scordo, M.; Sauter, C.; Batlevi, C.; Dahi, P. B.; Lin, R.; Palomba, M. L.; Perales, M. A.; Giralt, S. A.
    Quality of Life Research (2021)

    Fulltext@MSK | Save
  • Update of a phase II, multicenter study of high-dose chemotherapy with autologous stem cell transplant followed by maintenance romidepsin for T-cell lymphoma
    Meeting Abstract

    Khan, N.; Khimani, F.; Shustov, A. R.; Shadman, M.; Ruan, J.; Moskowitz, A. J.; Straus, D. J.; Kumar, A.; Sauter, C. S.; Zelenetz, A. D.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Oral proteasome inhibitor ixazomib for switch-maintenance prophylaxis of recurrent or late acute and chronic graft-versus-host disease after day 100 in allogeneic stem cell transplantation
    Journal Article

    Rodriguez, N.; Lee, J.; Flynn, L.; Murray, F.; Devlin, S. M.; Soto, C.; Cho, C.; Dahi, P.; Giralt, S.; Perales, M. A.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • The post-transplant scoring system (PTSS) is associated with outcomes in patients with MDS after CD34+ selected allogeneic stem cell transplant
    Journal Article

    Alarcon Tomas, A.; Whiting, K.; Maloy, M.; Ruiz, J. D.; Devlin, S.; Sanchez-Escamilla, M.; Yañez, L.; Castillo, N.; Pennisi, M.; Cho, C.; more...
    Bone Marrow Transplantation (2021)

    Fulltext@MSK | Save